Form D · Biotechnology
IMMUNEWORKS, INC.
Indianapolis, IN · CIK 0001364841
Offering snapshot reported Dec 26, 2013 · SEC filing
- Reported sold
- $60K Offering amount: $600K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Dec 12, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 26, 2013 | Initial | $60,000 | No comparison | 2 | SEC filing |
| Jul 17, 2009 | Initial | $375,000 | No comparison | 1 | SEC filing |
| Jan 22, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 13, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 19, 2006 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-208773
Source: Form D, filed Dec 26, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Shaun Hawkins | Director |
| Michael J. Klemsz | Director |
| Wade Lange | Director, Executive |
| Ronald L. Meeusen | Director |
| David S. Wilkes | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
351 West 10 Th Street Suite 251
Indianapolis, IN, 46202
Indianapolis, IN, 46202